|
TAF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.013800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.522250E-02 |
| Normal-vs-Stage2 |
1.815250E-01 |
| Normal-vs-Stage3 |
1.017620E-01 |
| Normal-vs-Stage4 |
6.091200E-01 |
| Stage1-vs-Stage2 |
8.531600E-01 |
| Stage1-vs-Stage3 |
4.284400E-01 |
| Stage1-vs-Stage4 |
6.623000E-01 |
| Stage2-vs-Stage3 |
7.019600E-01 |
| Stage2-vs-Stage4 |
5.816600E-01 |
| Stage3-vs-Stage4 |
3.434200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.767000E-04 |
| Normal-vs-AfricanAmerican |
1.521820E-01 |
| Normal-vs-Asian |
9.862400E-01 |
| Caucasian-vs-AfricanAmerican |
1.668790E-01 |
| Caucasian-vs-Asian |
4.198400E-01 |
| AfricanAmerican-vs-Asian |
6.162800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.262950E-03 |
| Normal-vs-Female |
3.579000E-03 |
| Male-vs-Female |
2.448200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.666600E-01 |
| Normal-vs-Extreme_Weight |
8.970300E-02 |
| Normal-vs-Obese |
1.598270E-03 |
| Normal-vs-Extreme_Obese |
7.397200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.638600E-01 |
| Normal_Weight-vs-Obese |
1.472830E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.136800E-01 |
| Extreme_Weight-vs-Obese |
1.613970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.751000E-01 |
| Obese-vs-Extreme_Obese |
1.051580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.415930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.59348999999587E-05 |
| Normal-vs-Age(61-80Yrs) |
9.983800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.760800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.746000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.134200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.637800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.375200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.849900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.329600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52068000000005E-05 |
| Normal-VS-Type2 PRCC |
6.998800E-01 |
| Normal-VS-KIRP CIMP |
7.995000E-01 |
| Normal-VS-Unclassified PRCC |
8.075200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.785700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.357200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.196400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.331000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.681300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.836000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.058400E-01 |
| Normal-vs-N1 |
2.594300E-02 |
| Normal-vs-N2 |
7.201600E-01 |
| N0-vs-N1 |
1.409600E-01 |
| N0-vs-N2 |
6.350600E-01 |
| N1-vs-N2 |
2.463000E-01 |
|
|
